Global Oxycodone Drugs Market Size study, by Product (Short-acting, Long-acting), by Distribution Channel, and Regional Forecasts 2022-2032

The Global Oxycodone Drugs Market was valued at approximately USD 0.4 billion in 2023 and is poised to grow at a steady compound annual growth rate (CAGR) of 4.80% over the forecast period 2024–2032. Oxycodone, a semi-synthetic opioid, has long served as a linchpin in the management of moderate to severe pain, offering both acute and chronic care relief across a broad spectrum of clinical settings. Its dual-release format—encompassing short-acting and long-acting formulations—enables clinicians to tailor pain management strategies based on individualized patient needs. As the prevalence of post-operative pain, cancer-related discomfort, and chronic musculoskeletal disorders continues to escalate globally, the demand for potent, flexible opioid analgesics like oxycodone is gaining renewed momentum.

The market is navigating a complex intersection of regulatory oversight and therapeutic necessity. On one hand, stringent guidelines aimed at curbing opioid misuse have prompted reforms in prescription practices, marketing approaches, and dispensing protocols. On the other, innovations in abuse-deterrent formulations, coupled with enhanced patient monitoring systems, are reinforcing the drug's clinical relevance. Pharmaceutical players are increasingly investing in extended-release technologies and combination therapies to offer longer-lasting relief with minimized risk profiles. These strategic advancements are being complemented by robust clinical research evaluating oxycodone’s efficacy across diverse pain categories, including neuropathic and breakthrough pain.

From a commercialization standpoint, the oxycodone drugs market is witnessing a perceptible shift toward long-acting variants, especially in palliative care and oncology support. Hospitals and pain management clinics are the primary demand centers, though the online and retail pharmacy segments are expanding rapidly as telehealth services grow more ubiquitous. With health systems emphasizing integrated pain management programs, oxycodone's role is being repositioned as part of multimodal approaches rather than standalone interventions. This evolution is also sparking renewed interest in co-crystal combinations and adjunctive delivery platforms such as transdermal systems and tamper-resistant capsules.

Geographically, North America continues to dominate the global oxycodone drugs market, underpinned by widespread clinical adoption, a high chronic pain burden, and advanced healthcare infrastructure. The United States remains a key player, although policy tightening has shifted the focus toward responsible prescribing and alternative therapies. In Europe, the market is supported by robust cancer care pathways and aging populations, while Asia Pacific is emerging as the fastest-growing region. Countries like India, China, and South Korea are enhancing their pharmaceutical regulatory environments and expanding palliative care programs, thereby fueling regional market expansion and accessibility to opioid-based therapies.

Major market player included in this report are:
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Mylan N.V.
• Endo International plc
• Sun Pharmaceutical Industries Ltd.
• Hikma Pharmaceuticals PLC
• Purdue Pharma L.P.
• Mallinckrodt Pharmaceuticals
• Johnson & Johnson
• Lupin Pharmaceuticals, Inc.
• Aurobindo Pharma Ltd.
• Novartis AG
• Glenmark Pharmaceuticals Ltd.
• Cipla Ltd.
• Dr. Reddy’s Laboratories Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product
• Short-acting
• Long-acting

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Global Oxycodone Drugs Market Executive Summary
1.1. Global Oxycodone Drugs Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product (Short acting, Long acting)
1.3.2. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Oxycodone Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Oxycodone Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Rising global burden of acute and chronic pain
3.1.2. Innovations in abuse deterrent and extended release formulations
3.1.3. Expansion of telehealth and e pharmacy channels
3.2. Market Challenges
3.2.1. Stringent opioid prescribing regulations
3.2.2. Risks of addiction and diversion
3.2.3. Competition from non opioid analgesics and alternative therapies
3.3. Market Opportunities
3.3.1. Growth in palliative care and oncology support programs
3.3.2. Emerging demand in Asia Pacific pain management
3.3.3. Development of novel delivery platforms (transdermal, tamper resistant)
Chapter 4. Global Oxycodone Drugs Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Model
4.1.7. Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Oxycodone Drugs Market Size & Forecasts by Product (2022–2032)
5.1. Segment Dashboard
5.2. Short acting Revenue Trend Analysis, 2022 & 2032
5.3. Long acting Revenue Trend Analysis, 2022 & 2032
Chapter 6. Global Oxycodone Drugs Market Size & Forecasts by Distribution Channel (2022–2032)
6.1. Segment Dashboard
6.2. Hospital Pharmacy Revenue Trend Analysis, 2022 & 2032
6.3. Retail Pharmacy Revenue Trend Analysis, 2022 & 2032
6.4. Online Pharmacy Revenue Trend Analysis, 2022 & 2032
Chapter 7. Global Oxycodone Drugs Market Size & Forecasts by Region (2022–2032)
7.1. North America Oxycodone Drugs Market
7.1.1. U.S. Market (2022–2032)
7.1.2. Canada Market (2022–2032)
7.2. Europe Oxycodone Drugs Market
7.2.1. U.K. Market
7.2.2. Germany Market
7.2.3. France Market
7.2.4. Spain Market
7.2.5. Italy Market
7.2.6. Rest of Europe Market
7.3. Asia Pacific Oxycodone Drugs Market
7.3.1. China Market
7.3.2. India Market
7.3.3. Japan Market
7.3.4. Australia Market
7.3.5. South Korea Market
7.3.6. Rest of Asia Pacific Market
7.4. Latin America Oxycodone Drugs Market
7.4.1. Brazil Market
7.4.2. Mexico Market
7.4.3. Rest of Latin America Market
7.5. Middle East & Africa Oxycodone Drugs Market
7.5.1. Saudi Arabia Market
7.5.2. South Africa Market
7.5.3. Rest of Middle East & Africa Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Teva Pharmaceutical Industries Ltd.
8.1.2. Pfizer Inc.
8.1.3. Mylan N.V.
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Teva Pharmaceutical Industries Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Pfizer Inc.
8.3.3. Mylan N.V.
8.3.4. Endo International plc
8.3.5. Sun Pharmaceutical Industries Ltd.
8.3.6. Hikma Pharmaceuticals PLC
8.3.7. Purdue Pharma L.P.
8.3.8. Mallinckrodt Pharmaceuticals
8.3.9. Johnson & Johnson
8.3.10. Lupin Pharmaceuticals, Inc.
8.3.11. Aurobindo Pharma Ltd.
8.3.12. Novartis AG
8.3.13. Glenmark Pharmaceuticals Ltd.
8.3.14. Cipla Ltd.
8.3.15. Dr. Reddy’s Laboratories Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Global Oxycodone Drugs market, report scope
TABLE 2. Global Oxycodone Drugs market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Oxycodone Drugs market estimates & forecasts by Product 2022–2032 (USD Million)
TABLE 4. Global Oxycodone Drugs market estimates & forecasts by Distribution Channel 2022–2032 (USD Million)
TABLE 5. North America Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 6. U.S. Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 7. Canada Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. Europe Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.K. Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. Germany Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 11. France Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Spain Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 13. Italy Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Rest of Europe Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. Asia Pacific Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. China Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. India Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Japan Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Australia Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. South Korea Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 21. Rest of Asia Pacific Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 22. Latin America Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 23. Brazil Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 24. Mexico Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 25. Rest of Latin America Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 26. Middle East & Africa Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 27. Saudi Arabia Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 28. South Africa Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
TABLE 29. Rest of Middle East & Africa Oxycodone Drugs market estimates & forecasts, 2022–2032 (USD Million)
List of Figures
FIGURE 1. Global Oxycodone Drugs market research methodology
FIGURE 2. Global Oxycodone Drugs market estimation techniques
FIGURE 3. Global market size estimates & forecast methods
FIGURE 4. Global Oxycodone Drugs market key trends 2023
FIGURE 5. Global Oxycodone Drugs market growth prospects 2022–2032
FIGURE 6. Global Oxycodone Drugs market Porter’s Five Forces model
FIGURE 7. Global Oxycodone Drugs market PESTEL analysis
FIGURE 8. Global Oxycodone Drugs market value chain analysis
FIGURE 9. Global Oxycodone Drugs market by Product, 2022 & 2032
FIGURE 10. Global Oxycodone Drugs market by Distribution Channel, 2022 & 2032
FIGURE 11. Global Oxycodone Drugs regional snapshot 2022 & 2032
FIGURE 12. North America Oxycodone Drugs market 2022 & 2032
FIGURE 13. Europe Oxycodone Drugs market 2022 & 2032
FIGURE 14. Asia Pacific Oxycodone Drugs market 2022 & 2032
FIGURE 15. Latin America Oxycodone Drugs market 2022 & 2032
FIGURE 16. Middle East & Africa Oxycodone Drugs market 2022 & 2032
FIGURE 17. Global Oxycodone Drugs market company market share analysis (2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings